Biology of colorectal pulmonary metastasis: Implications for surgical resection

Interactive Cardiovascular and Thoracic Surgery

Volumn 14, Issue 2, 2012, Pages 140-142

  Poullis, Michael ^a   Littler, John ^b   Gosney, John ^c  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b CLATTERBRIDGE HOSPITAL   (United Kingdom)

^c Liverpool Royal Hospital   (United Kingdom)

Author keywords

Colon cancer; Metastasectomy; Tumour doubling time

Indexed keywords

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER MODEL; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONE BEAM COMPUTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LUNG METASTASIS; METASTASIS RESECTION; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR VASCULARIZATION; TUMOR VOLUME;

CELL PROLIFERATION; COLORECTAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; METASTASECTOMY; MODELS, BIOLOGICAL; PATIENT SELECTION; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856950952     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivr050     Document Type: Article

References (13)

1. Treasure T, Fallowfield L, Lees B. Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial. J Thorac Oncol 2010;5:S203-6.
2. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66. (Pubitemid 41817714)
3. Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I et al. Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis. World J Surg 2004;28:263-70. (Pubitemid 38375526)
4. Takakura Y, Miyata Y, Okajima M, Okada M, Ohdan H. Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer. Colorectal Dis 2010;12:e68-75.
5. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Ishizu K et al. Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis. Jpn J Clin Oncol 2005;35:18-22. (Pubitemid 40450550)
6. Nomura K, Miyagawa S, Harada H, Kitamura H, Seki H, Shimada R et al. Relationship between doubling time of liver metastases from colorectal carcinoma and residual primary cancer. Dig Surg 1998;15:21-4. (Pubitemid 28048385)
7. Tomimaru Y, Noura S, Ohue M, Okami J, Oda K, Higashiyama M et al. Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer. Dig Surg 2008;25:220-5.
8. Perry MC. The Chemotherapy Source Book, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2007.
9. Ito K, Hibi K, Ando H, Hidemura K, Yamazaki T, Akiyama S et al. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma. Jpn J Clin Oncol 2002;32:54-8. (Pubitemid 41288785)
10. Ahmed FE. Artificial neural networks for diagnosis and survival prediction in colon cancer. Mol Cancer 2005;4:29.
11. Abbod MF, Catto JW, Linkens DA, Hamdy FC. Application of artificial intelligence to the management of urological cancer. J Urol 2007;178:1150-6. (Pubitemid 47368386)
12. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6. (Pubitemid 20020880)
13. Sone S, Hanaoka T, Ogata H, Takayama F, Watanabe T, Haniuda M et al. Small peripheral lung carcinomas with five-year post-surgical follow-up: assessment by semi-automated volumetric measurement of tumour size, CT value and growth rate on TSCT. Eur Radiol 2011 Epub ahead of print. DOI:10.1007/S00330- 011-2241-0. PMID 21847540.